Catalyst Wire Dossier Catalyst Wire Dossier

TSN2898

· Thesan Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TSN2898, covering 2017-04-26 to 2017-04-26. Get the full timeline:

Most recent: Clinical Trial Update: TSN2898-201 Safety and Efficacy of TSN2898 in the Treatment of Acne Vulgaris [Phase 2]

See pricing